Hematology and Oncology Associates of North East Pennsylvania — Scranton, Pennsylvania

Hematology and Oncology Associates of North East Pennsylvania is a clinical research site located in Scranton, Pennsylvania, United States 18508.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Hematology and Oncology Associates of North East Pennsylvania has participated in 38 clinical trials with 14 currently active.

Therapeutic areas: Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), GOG Foundation, Gynecologic Oncology Group.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology and Oncology Associates of North East Pennsylvania?

Hematology and Oncology Associates of North East Pennsylvania has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology and Oncology Associates of North East Pennsylvania conducted?

Hematology and Oncology Associates of North East Pennsylvania has 38 clinical trials on record, with 14 currently active. Their work covers Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.

Is Hematology and Oncology Associates of North East Pennsylvania accredited by Crixeo Health?

Hematology and Oncology Associates of North East Pennsylvania has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hematology and Oncology Associates of North East Pennsylvania?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.